Werfen is a growing, family-owned, and innovative company founded in 1966 in Barcelona, Spain. We operate directly in nearly 30 countries and in more than 100 territories through distributors, with headquarters and Technology Centers located in Europe and the United States. The Immunoassay Technology Center in Barcelona has consolidated experience in the research, development, and manufacturing of IVD immunoassays and biomaterials.
Innovation is one of Werfen’s fundamental pillars, and we innovate at all levels, from diagnostic targets, biomaterials and reagents, protein production processes and assay technologies. We strive to strengthen our immunoassay know-how and technological capabilities with the ultimate goal of increasing efficiency and robustness, reducing time-to-market, and streamlining operations.
Werfen open innovation strategy is based on engagement with biotech companies and research institutions. We seek co-development or in-licensing opportunities.
Marina Bruch
Scientist
Partnership Goal
Werfen open innovation strategy is based on engagement with biotech companies and research institutions. We seek co-development or in-licensing opportunities.